189 related articles for article (PubMed ID: 20971173)
21. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres.
Kasper FK; Kushibiki T; Kimura Y; Mikos AG; Tabata Y
J Control Release; 2005 Oct; 107(3):547-61. PubMed ID: 16139915
[TBL] [Abstract][Full Text] [Related]
22. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition.
Nam K; Watanabe J; Ishihara K
Eur J Pharm Sci; 2004 Nov; 23(3):261-70. PubMed ID: 15489127
[TBL] [Abstract][Full Text] [Related]
23. Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microspheres for bone regeneration.
Leeuwenburgh SC; Jo J; Wang H; Yamamoto M; Jansen JA; Tabata Y
Biomacromolecules; 2010 Oct; 11(10):2653-9. PubMed ID: 20804200
[TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
25. Formation of model hepatocellular aggregates in a hydrogel scaffold using degradable genipin crosslinked gelatin microspheres as cell carriers.
Lau TT; Lee LQ; Leong W; Wang DA
Biomed Mater; 2012 Dec; 7(6):065003. PubMed ID: 23117748
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.
Das MK; Senapati PC
Acta Pol Pharm; 2007; 64(3):253-62. PubMed ID: 17695149
[TBL] [Abstract][Full Text] [Related]
27. Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman.
Gupta KC; Jabrail FH
Carbohydr Res; 2007 Nov; 342(15):2244-52. PubMed ID: 17610856
[TBL] [Abstract][Full Text] [Related]
28. New amphiphilic and pH-sensitive hydrogel for controlled release of a model poorly water-soluble drug.
Colinet I; Dulong V; Mocanu G; Picton L; Le Cerf D
Eur J Pharm Biopharm; 2009 Nov; 73(3):345-50. PubMed ID: 19631739
[TBL] [Abstract][Full Text] [Related]
29. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.
Gupta KC; Jabrail FH
Carbohydr Res; 2006 May; 341(6):744-56. PubMed ID: 16499893
[TBL] [Abstract][Full Text] [Related]
30. A study of drug release from homogeneous PLGA microstructures.
Acharya G; Shin CS; Vedantham K; McDermott M; Rish T; Hansen K; Fu Y; Park K
J Control Release; 2010 Sep; 146(2):201-6. PubMed ID: 20381555
[TBL] [Abstract][Full Text] [Related]
31. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
Wang LY; Ma GH; Su ZG
J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
[TBL] [Abstract][Full Text] [Related]
32. Biodegradation and drug release studies of BSA loaded gelatin microspheres.
Mladenovska K; Kumbaradzi E; Dodov G; Makraduli L; Goracinova K
Int J Pharm; 2002 Aug; 242(1-2):247-9. PubMed ID: 12176256
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
Alsarra IA
Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
[TBL] [Abstract][Full Text] [Related]
34. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies.
Liang HC; Chang WH; Lin KJ; Sung HW
J Biomed Mater Res A; 2003 May; 65(2):271-82. PubMed ID: 12734822
[TBL] [Abstract][Full Text] [Related]
35. Modifying the release of proxyphylline from PVA hydrogels using surface crosslinking.
Wu L; Brazel CS
Int J Pharm; 2008 Feb; 349(1-2):144-51. PubMed ID: 17875374
[TBL] [Abstract][Full Text] [Related]
36. Electrically controlled release of sulfosalicylic acid from crosslinked poly(vinyl alcohol) hydrogel.
Juntanon K; Niamlang S; Rujiravanit R; Sirivat A
Int J Pharm; 2008 May; 356(1-2):1-11. PubMed ID: 18242901
[TBL] [Abstract][Full Text] [Related]
37. Casein-based formulations as promising controlled release drug delivery systems.
Elzoghby AO; El-Fotoh WS; Elgindy NA
J Control Release; 2011 Aug; 153(3):206-16. PubMed ID: 21338636
[TBL] [Abstract][Full Text] [Related]
38. Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release.
Curcio M; Gianfranco Spizzirri U; Iemma F; Puoci F; Cirillo G; Parisi OI; Picci N
Eur J Pharm Biopharm; 2010 Sep; 76(1):48-55. PubMed ID: 20580821
[TBL] [Abstract][Full Text] [Related]
39. Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy.
Saito T; Tabata Y
Acta Biomater; 2012 Feb; 8(2):646-52. PubMed ID: 22079782
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of cross-linked chitosan microparticles containing metronidazole for periodontitis treatment.
Pichayakorn W; Boonme P
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1197-202. PubMed ID: 23827560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
